{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:05Z","timestamp":1760188445254},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf00442685","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T05:11:09Z","timestamp":1100236269000},"page":"233-238","source":"Crossref","is-referenced-by-count":15,"title":["Lipoprotein profiles at different stages of the nephrotic syndrome"],"prefix":"10.1007","volume":"147","author":[{"given":"U.","family":"Querfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gnasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Haberbosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sch\ufffdrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"207","volume":"II","author":"JH Alexander","year":"1974","unstructured":"Alexander JH, Schapel GJ, Edwards KDG (1974) Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man. Med J Aust II:207?208","journal-title":"Med J Aust"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI104277","volume":"40","author":"JC Allen","year":"1961","unstructured":"Allen JC, Baxter JH, Goodman HC (1961) Effects of dextran, polyvinylpyrrolidone and gamma globulin on the hyperlipidaemia of experimental nephrosis. J Clin Invest 40:499?508","journal-title":"J Clin Invest"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI104058","volume":"39","author":"JH Baxter","year":"1960","unstructured":"Baxter JH, Goodman HC, Havel RJ (1960) Serum lipid and lipoprotein alterations in nephrosis. J Clin Invest 39:455?465","journal-title":"J Clin Invest"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(69)90110-X","volume":"II","author":"GM Berlyne","year":"1969","unstructured":"Berlyne GM, Mallick NP (1969) Ischaemic heart disease as a complication of nephrotic syndrome. Lancet II:399?400","journal-title":"Lancet"},{"key":"CR5","first-page":"909","volume":"113","author":"CH Breier","year":"1983","unstructured":"Breier CH, Lisch HJ, Drexel H, Braunsteiner H (1983) Lipoproteine, Apoproteine, hepatische Triglyceridlipase und Lecithin-Cholesterin-Acyl-Transferase bei Patienten mit nephrotischem Syndrom. Schweiz Med Wochenschr 113:909?913","journal-title":"Schweiz Med Wochenschr"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2008-1033800","volume":"194","author":"J Brodehl","year":"1982","unstructured":"Brodehl J, Krohn HP, Ehrich JHH (1982) The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative study of the Arbeitsgemeinschaft f\u00fcr p\u00e4diatrische Nephrologie (APN). Klin Padiatr 194:162?165","journal-title":"Klin Padiatr"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1445-5994.1984.tb03786.x","volume":"14","author":"MK Chan","year":"1984","unstructured":"Chan MK, Persaud JW, Varghese Z, Moorhead JF (1984) Postheparin hepatic and lipoprotein lipase activities in nephrotic syndrome. Aust NZ J Med 14:841?847","journal-title":"Aust NZ J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0140-6736(71)91044-0","volume":"I","author":"JS Chopra","year":"1971","unstructured":"Chopra JS, Mallick NP, Stone MC (1971) Hyperlipoproteinaemias in nephrotic syndrome. Lancet I:317?320","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9343(77)90231-5","volume":"63","author":"RC Curry","year":"1977","unstructured":"Curry RC, Roberts WC (1977) Status of the coronary arteries in the nephrotic syndrome. Am J Med 63:183?192","journal-title":"Am J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0026-0495(76)90022-6","volume":"25","author":"SG DeMendoza","year":"1976","unstructured":"DeMendoza SG, Kashyap ML, Chen CJ, Lutmo RF (1976) High density lipoproteinuria in nephrotic syndrome. Metabolism 25:1143?1149","journal-title":"Metabolism"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-2275(20)34369-8","volume":"26","author":"H Dieplinger","year":"1985","unstructured":"Dieplinger H, Zechner R, Kostner GM (1985) The in vitro formation of HDL2 during the action of LCAT: the role of triglyceriderich lipoproteins. J Lipid Res 26:273?282","journal-title":"J Lipid Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","volume":"50","author":"CW Dunnet","year":"1955","unstructured":"Dunnet CW (1955) A multiple comparisons procedure for comparing several treatments with a control. J Am Statis Assoc 50: 1096?1121","journal-title":"J Am Statis Assoc"},{"key":"CR13","first-page":"472","volume":"3","author":"M Fainaru","year":"1977","unstructured":"Fainaru M, Eisenberg S (1977) Dissociation of apolipoprotein A-I from human high density lipoprotein particles. Artery 3:472?488","journal-title":"Artery"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2362.1977.tb01652.x","volume":"7","author":"E Gherardi","year":"1977","unstructured":"Gherardi E, Rota E, Calandra S, Genova R, Tamborino A (1977) Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest 7:563?570","journal-title":"Eur J Clin Invest"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1016\/S0021-9258(18)32346-9","volume":"258","author":"CK Glass","year":"1983","unstructured":"Glass CK, Pittmann RC, Keller GA, Steinberg D (1983) Tissue sites of degradation of apoprotein A-1 in the rat. J Biol Chem 258:7161?7167","journal-title":"J Biol Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0025-7125(16)31054-9","volume":"69","author":"L Goldberg","year":"1985","unstructured":"Goldberg L, Elliot DL (1985) The effect of physical activity on lipid and lipoprotein levels. Med Clin North Am 69:41?55","journal-title":"Med Clin North Am"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.1977.75","volume":"112","author":"AK Goldberg","year":"1977","unstructured":"Goldberg AK, Eliaschewitz FG, Quintao ECR (1977) Origin of hypercholesterolemia in chronic experimental nephrotic syndrome. Kidney Int 112:23?27","journal-title":"Kidney Int"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC (1977) High-density lipoprotein as a protective factor against coronary heart disease: the Framinghham study. Am J Med 62:707?714","journal-title":"Am J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"International Study of Kidney Disease in Children","year":"1978","unstructured":"International Study of Kidney Disease in Children (1978) The nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory charactristics at the time of diagnosis. Kidney Int 13:159?165","journal-title":"Kidney Int"},{"key":"CR20","first-page":"976","volume":"131","author":"RJ Kallen","year":"1977","unstructured":"Kallen RJ, Brynes RK, Aronson AJ, Lichtig C, Spargo BH (1977) Premature coronary atherosclerosis in a 5-year-old with corticosteroid-refractory nephrotic syndrome. Am J Dis Child 131:976?980","journal-title":"Am J Dis Child"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","volume":"74","author":"WB Kannel","year":"1971","unstructured":"Kannel WB, Castelli WP, Gordon T (1971) Serum cholesterol, lipoproteins and the risk of coronary heart disease. Ann Intern Med 74:1?12","journal-title":"Ann Intern Med"},{"key":"CR22","first-page":"191","volume":"7","author":"RG Kladetzky","year":"1980","unstructured":"Kladetzky RG, Assmann G, Walgenback S, Tauchert P, Helb HD (1980) Lipoprotein and apoprotein values in coronary angiography patients. Artery 7:191?205","journal-title":"Artery"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0009-8981(79)90187-6","volume":"94","author":"M Lopes-Virella","year":"1979","unstructured":"Lopes-Virella M, Virella G, Debeukelaer M, Owens CJ, Colwell JA (1979) Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies. Clin Chim Acta 94:73?81","journal-title":"Clin Chim Acta"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000182024","volume":"27","author":"NP Mallick","year":"1981","unstructured":"Mallick NP, Shore CD (1981) The nephrotic syndrome and ischemic heart disease. Nephron 27:54?57","journal-title":"Nephron"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198308183090701","volume":"309","author":"I Maciejko","year":"1983","unstructured":"Maciejko I, Holmes DTC, Kottke I (1983) Apolipoprotein AI as a marker of angiographically assessed coronary artery disease. N Engl J Med 309:385?389","journal-title":"N Engl J Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0022-2275(20)34440-0","volume":"25","author":"JB Marsh","year":"1984","unstructured":"Marsh JB (1984) Lipoprotein metabolism in experimental nephrosis. J Lipid Res 25:1619?1623","journal-title":"J Lipid Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0026-0495(79)90008-8","volume":"28","author":"JB Marsh","year":"1979","unstructured":"Marsh JB, Sparks CE (1979) Lipoproteins in experimental nephrosis: Plasma levels and composition. Metabolism 28:1040?1045","journal-title":"Metabolism"},{"key":"CR28","first-page":"798","volume":"103","author":"RS Martin","year":"1984","unstructured":"Martin RS, Small D (1984) Physicochemical characterization of the urinary lipid from humans with nephrotic syndrome. J Lab Clin Med 103:798?810","journal-title":"J Lab Clin Med"},{"key":"CR29","first-page":"1001","volume":"17","author":"J Michaeli","year":"1981","unstructured":"Michaeli J, Bar-on H, Shafrir E (1981) Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome. Isr J Med Sci 17:1001?1008","journal-title":"Isr J Med Sci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(85)90181-9","volume":"54","author":"E Muls","year":"1985","unstructured":"Muls E, Rosseneu M, Daneels R, Schurgers M, Boelaert J (1985) Lipoprotein distribution and composition in the human nephrotic syndrome. Atherosclerosis 54:225?237","journal-title":"Atherosclerosis"},{"key":"CR31","first-page":"359","volume":"50","author":"S Newmark","year":"1975","unstructured":"Newmark S, Anderson CF, Donadio JV, Ellefson RD (1975) Lipoprotein profiles in adult nephrotics. Mayo Clinic Proc 50:359?364","journal-title":"Mayo Clinic Proc"},{"key":"CR32","first-page":"64","volume":"14","author":"OH Oetliker","year":"1980","unstructured":"Oetliker OH, Mordasini R, Luetschg J, Riesen W (1980) Lipoprotein metabolism in nephrotic syndrome in childhood. Pediatr Res 14:64?66","journal-title":"Pediatr Res"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-8981(81)90034-6","volume":"117","author":"T Ohta","year":"1981","unstructured":"Ohta T, Matsuda I (1981) Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chim Acta 117:133?143","journal-title":"Clin Chim Acta"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1984.190","volume":"26","author":"DR Peterson","year":"1984","unstructured":"Peterson DR, Hjelle JT, Carone FA, Moore PA (1984) Renal handling of plasma high density lipoprotein. Kidney Int 26:411?421","journal-title":"Kidney Int"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000183556","volume":"41","author":"J Sasaki","year":"1985","unstructured":"Sasaki J, Fumihiko H, Motooka T, Naito S, Arakawa K (1985) Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy. Nephron 41: 110?113","journal-title":"Nephron"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2307\/3002019","volume":"2","author":"FE Satterthwhaite","year":"1946","unstructured":"Satterthwhaite FE (1946) An approximate distribution of estimates of variance components. Biometrics 2:110?114","journal-title":"Biometrics"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF02533892","volume":"14","author":"E Shafrir","year":"1979","unstructured":"Shafrir E, Brenner T (1979) Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I. Studies in rat in vivo. Lipids 14:695?702","journal-title":"Lipids"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0026-0495(82)90062-2","volume":"31","author":"VG Shore","year":"1982","unstructured":"Shore VG, Forte T, Licht H, Lewis SB (1982) Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins. Metabolism 31:258?268","journal-title":"Metabolism"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/ki.1986.131","volume":"29","author":"CD Short","year":"1986","unstructured":"Short CD, Durrington PN, Mallick NP, Hunt LP, Tetlow L, Ishola M (1986) Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int 29:1224?1228","journal-title":"Kidney Int"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000183207","volume":"37","author":"IV Sokolovskaya","year":"1984","unstructured":"Sokolovskaya IV, Nikiforova NV (1984) High density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome. Nephron 37:49?53","journal-title":"Nephron"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0026-0495(81)90115-3","volume":"30","author":"CE Sparks","year":"1981","unstructured":"Sparks CE, Tennenberg SD, Marsh JB (1981) Catabolism of apoprotein A-1 of HDL in normal and nephrotic rats. Metabolism 30:354?358","journal-title":"Metabolism"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2307\/3001913","volume":"5","author":"JW Tukey","year":"1949","unstructured":"Tukey JW (1949) Comparing individual means in the analysis of variance. Biometrics 5:99?114","journal-title":"Biometrics"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(79)92067-1","volume":"II","author":"VJ Wass","year":"1979","unstructured":"Wass VJ, Chilvers C, Jarrett RJ, Cameron JS (1979) Does the nephrotic syndrome increase the risk of cardiovascular disease? Lancet II:664?667","journal-title":"Lancet"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000182025","volume":"27","author":"V Wass","year":"1981","unstructured":"Wass V, Cameron JS (1981) Cardiovascular disease and the nephrotic syndrome: the other side of the coin. Nephron 27:58?61","journal-title":"Nephron"},{"key":"CR45","first-page":"191","volume":"8","author":"K Widhalm","year":"1980","unstructured":"Widhalm K, Singer P, Balzar E (1980) Serumlipoproteins in children with nephrotic syndrome and chronic renal failure. Artery 8:191?198","journal-title":"Artery"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0009-8981(70)90276-7","volume":"30","author":"M Yamada","year":"1970","unstructured":"Yamada M, Matsuda I (1970) Lipoprotein lipase in clinical and experimental nephrosis. Clin Chim Acta 30:787?794","journal-title":"Clin Chim Acta"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3476(84)80590-9","volume":"104","author":"G Zilleruelo","year":"1984","unstructured":"Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J (1984) Persistence of serum abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 104:61?64","journal-title":"J Pediatr"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0026-0495(84)90006-4","volume":"33","author":"J Zimmermann","year":"1984","unstructured":"Zimmermann J, Fainaru M, Eisenberg S (1984) The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism 33:521?526","journal-title":"Metabolism"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00442685\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T06:23:38Z","timestamp":1624861418000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00442685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF00442685"],"URL":"https:\/\/doi.org\/10.1007\/bf00442685","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}